中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共8条，第1-8条

帮助

条数/页：排序方式：
	Repurposing of Kinase Inhibitors for Treatment of COVID-19 期刊论文 OAI收割 PHARMACEUTICAL RESEARCH, 2020, 卷号: 37 作者: Weisberg, Ellen; Parent, Alexander; Yang, Priscilla L.; Sattler, Martin; Liu, Qingsong \| 收藏 \| 浏览/下载：59/0 \| 提交时间：2020/10/26 Coronavirus SARS-CoV-2 SARS-CoV MERS-CoV kinase inhibitors pharmacokinetics antiviral therapy COVID-19
	Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma 期刊论文 OAI收割 CANCER RESEARCH, 2017, 卷号: 77, 期号: 18, 页码: 5068-5076 作者: Liu, Yan; Li, Yuyang; Wang, Xiaoen; Liu, Feiyang; Gao, Peng \| 收藏 \| 浏览/下载：49/0 \| 提交时间：2018/08/16
	Structure-activity relationship investigation for benzonaphthyridinone derivatives as novel potent Bruton's tyrosine kinase (BTK) irreversible inhibitors 期刊论文 OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 137, 页码: 545-557 作者: Wang, Beilei; Deng, Yuanxin; Chen, Yongfei; Yu, Kailin; Wang, Aoli \| 收藏 \| 浏览/下载：51/0 \| 提交时间：2018/08/16 Btk Kinase Inhibitor Irreversible Inhibitor Structure-activity Relationship B-cell Lymphoma
	Irreversible inhibition of BTK kinase by a novel highly selective inhibitor CHMFL-BTK-11 suppresses inflammatory response in rheumatoid arthritis model 期刊论文 OAI收割 SCIENTIFIC REPORTS, 2017, 卷号: 7, 期号: 无, 页码: 1-10 作者: Wu, Hong; Huang, Qiong; Qi, Ziping; Chen, Yongfei; Wang, Aoli \| 收藏 \| 浏览/下载：55/0 \| 提交时间：2018/07/04
	Ibrutinib targets mutant-EGFR kinase with a distinct binding conformation 期刊论文 OAI收割 ONCOTARGET, 2016, 卷号: 7, 期号: 43, 页码: 69760-69769 作者: Wang, Aoli; Yan, Xiao-E; Wu, Hong; Wang, Wenchao; Hu, Chen 收藏 \| 浏览/下载：91/0 \| 提交时间：2017/11/21 Ibrutinib Egfr Kinase Dfg-in/c-helix-out Inactive Conformation Nsclc
	Identification of Wee1 and IGF-1R As Novel Therapeutic Targets for Mutant RAS-Driven Acute Leukemia By Combinatory Chemical Screens 期刊论文 OAI收割 BLOOD, 2014, 卷号: 124, 期号: 21, 页码: 3 作者: Nonami, Atsushi; Zhao, Chen; Liu Qingsong; Cowens, Kristen; Christie, Amanda L. \| 收藏 \| 浏览/下载：19/0 \| 提交时间：2019/06/03
	Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery_ 期刊论文 OAI收割 ACS CHEMICAL BIOLOGY, 2014, 卷号: 9, 期号: 6, 页码: 1230-1241 作者: Zheng Zhao; Hong Wu; Li Wang; Yi Liu; Stefan Knapp 收藏 \| 浏览/下载：14/0 \| 提交时间：2016/11/23
	Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase of a Potent and Selective DDR1 Receptor Tyrosine Kinase 期刊论文 OAI收割 acs chem. biol., 2013, 卷号: 8, 页码: 2145-2150 Hyung-Gu Kim,Li Tan,Ellen L. Weisberg,Feiyang Liu, Peter Canning，Hwan Geun Choi, Scott A. Ezell,Hong Wu, Zheng Zhao, Jinhua Wang, Anna Mandinova,James D. Griffin, Alex N. Bullock, Qingsong Liu,,‡ Sam W. Lee, Nathanael S. Gray 收藏 \| 浏览/下载：61/0 \| 提交时间：2014/07/30